Correction: Met Is the Most Frequently Amplified Gene in Endometriosis-Associated Ovarian Clear Cell Adenocarcinoma and Correlates with Worsened Prognosis

The provided text is a correction notice rather than original research, referencing underlying image data and repeat immunoblot/qRT-PCR materials for proteins in the AKT pathway (including AKT1, AKT2, C-Met/Met, and phosphorylated AKT). The core action of the correction is to supply or clarify the associated supplemental data used in the study’s figures, including a repeated AKT2 immunoblot from an independent experiment. The limitation is that no new biological analyses, patient cohort details, or results are described within the correction text itself. This paper is centrally about endometriosis — it specifically addresses Met amplification in endometriosis-associated ovarian clear cell adenocarcinoma and its prognostic correlation.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works